ObjectiveTo analysis of the causes or influencing factors of carcinomatous fatigue (CRF) in patients with lung neoplasms and the influence of CRF on the quality of life of the patients. Methods156 cases of lung neoplasms patients who were treated in our hospital from September 2013 to December 2016 were selected, which were evaluated by the cancer fatigue scale and the quality of life assessment scale after admission. The patients receiving chemotherapy were evaluated again for seventh days of chemotherapy. Results108 cases were tired of the 156 patients. The incidence of fatigue was 69.3%. The highest proportion of patients with moderate fatigue. The average score of the patient′s PFS scale was (5.56±2.44) points. The results of multiple factor Logistic regression analysis showed that, hemoglobin and serum albumin levels are risk factors for carcinonic fatigue in patients with lung neoplasms. The fatigue score of lung neoplasms patients after chemotherapy was significantly higher than that before chemotherapy (P＜0.05). The incidence of fatigue was significantly higher than that before chemotherapy (P＜0.05). The results of Pearson correlation analysis show that, there was a negative correlation between the carcinomatous fatiguescore and the quality of life score of the patients with lung neoplasms (P＜0.05). ConclusionHypohemoglobin, hypoalbuminemia, chemotherapy and carcinomatous fatigue in patients with lung neoplasms. Carcinomatous fatigue can seriously affect the physical and mental health of the patients. Attention should be given to the treatment.

无